date,title,source
Nov-01-18,Celyad to Present New CYAD-01 Data from THINK Study in Relapsed/Refractory Acute Myeloid Leukemia at 2018 ASH Annual Meeting,GlobeNewswire
Nov-09-18,Celyad Presents Update on CYAD-01 Solid Tumor Clinical Program at the SITC 33rd Annual Meeting,GlobeNewswire
Nov-15-18,Celyad to Participate at Upcoming Healthcare Conferences,GlobeNewswire
Nov-21-18,Celyad Announces Third Quarter 2018 Business Update,GlobeNewswire
Nov-30-18,"The Daily Biotech Pulse: EC Nod For Shire, Mirati Gets FDA Clearance For Cancer Drug Trials, PhaseBio's First Earnings",Benzinga
Nov-30-18,"Celyad Doses First mCRC Patient in the Phase 1 alloSHRINK Trial Evaluating Non-Gene Edited Allogeneic CAR-T Candidate, CYAD-101",GlobeNewswire
Dec-04-18,Celyad Presents Update on CYAD-01 Hematological Malignancies Clinical Program at 60th ASH Annual Meeting,GlobeNewswire
Jan-07-19,Celyad Outlines Key 2019 Priorities Including the Acceleration of the CYAD-01 Program in r/r AML and MDS,GlobeNewswire
Feb-21-19,Celyad Announces February and March 2019 Investor Conference Schedule,GlobeNewswire
Mar-08-19,Celyad Appoints Anne Moore as Vice President Corporate Strategy,GlobeNewswire
Mar-11-19,"Celyad to Host R&D Day and Webcast on Monday, March 18 in New York City",GlobeNewswire
Mar-18-19,Celyads 2019 R&D Day Highlights shRNA Platform and Pipeline of Next-generation NKG2D-based and Off-the-Shelf Non-gene Edited CAR-T Candidates,GlobeNewswire
Mar-28-19,Celyad Reports Business Update and Full Year 2018 Financial and Operating Results,GlobeNewswire
Mar-28-19,Celyad Appoints Filippo Petti as Chief Executive Officer,GlobeNewswire
Apr-01-19,Celyad Announces April 2019 Investor Conference Schedule,GlobeNewswire
Apr-17-19,Celyad to Present Update on allogeneic and autologous NKG2D-based CAR-T Candidates in Refractory mCRC at ESMO 21st World GI Congress,GlobeNewswire
May-02-19,Celyad Announces May 2019 Investor Conference Schedule,GlobeNewswire
May-09-19,Celyad Announces First Quarter 2019 Financial Results and Recent Business Highlights,GlobeNewswire
May-16-19,Celyad to Present Data at 24th Congress of the European Hematology Association,GlobeNewswire
May-29-19,Celyad to Participate in Upcoming June 2019 Conferences,GlobeNewswire
Jun-03-19,Celyad Sees Hammer Chart Pattern: Time to Buy?,Zacks
